HCA Healthcare has appointed Michael Schlosser as executive vice president and chief clinical officer and created a new Ambulatory Operations Group led by Charles Gressle, consolidating oversight of clinical services, digital transformation, and more than 2,700 outpatient facilities as part of a leadership realignment taking effect in 2026. Schlosser will simultaneously run the Clinical Services Group and digital transformation and clinical informatics efforts, tightening the link between care quality, technology deployment, and operational decision-making. The reorganization does not materially change the near-term story, which still turns most on payer mix pressures and Medicaid-related reimbursement risk, with HCA reaffirming 2026 guidance that projects net income of US$6.3 billion to US$6.7 billion. Some analysts had already assumed HCA could reach about US$90.0 billion of revenue and US$7.6 billion of earnings, and the leadership changes may either strengthen that upside or test it if payer mix and exchange-related risks prove tougher than expected.
HCA Healthcare, Inc.Leadership realignment and reaffirmed guidance; impact on earnings uncertain.
